Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
202.53M | 182.71M | 137.76M | 143.31M | 131.06M | Gross Profit |
76.27M | 64.86M | 56.60M | 53.36M | 51.04M | EBIT |
21.19M | 15.25M | 11.09M | 7.81M | 10.73M | EBITDA |
29.25M | 22.13M | 20.78M | 20.34M | 19.97M | Net Income Common Stockholders |
15.32M | 11.36M | 9.20M | 5.46M | 9.56M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
55.16M | 41.45M | 40.37M | 32.29M | 20.57M | Total Assets |
252.50M | 210.69M | 203.17M | 190.88M | 154.41M | Total Debt |
40.51M | 34.98M | 39.52M | 37.38M | 32.77M | Net Debt |
-14.65M | -6.47M | -851.00K | 5.09M | 12.20M | Total Liabilities |
142.66M | 110.91M | 113.98M | 105.83M | 72.62M | Stockholders Equity |
108.67M | 97.02M | 83.97M | 79.31M | 75.54M |
Cash Flow | Free Cash Flow | |||
16.36M | 11.29M | 17.52M | 14.97M | 8.94M | Operating Cash Flow |
23.02M | 16.52M | 19.52M | 16.22M | 11.60M | Investing Cash Flow |
-6.16M | -6.11M | -2.37M | -2.54M | -2.63M | Financing Cash Flow |
-16.92M | -10.57M | -8.70M | -1.55M | -7.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £2.55B | 17.97 | -23.92% | 1.80% | 10.36% | 32.77% | |
78 Outperform | £723.89M | 32.03 | 18.73% | 1.00% | 13.49% | 47.00% | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.38% | 3.96% | -12.36% | |
$72.60B | 30.01 | 17.85% | 1.74% | ― | ― | ||
76 Outperform | £504.65M | 25.87 | 16.39% | 1.96% | 3.13% | 24.54% | |
74 Outperform | £1.20B | 30.70 | 11.62% | 1.77% | 8.00% | 674.47% | |
68 Neutral | £503.76M | 99.36 | 4.18% | 1.13% | 14.69% | ― |
Cohort plc has applied to the London Stock Exchange for the admission of 1,825,000 ordinary shares to be traded on AIM, with the expected admission date of 14 May 2025. These shares are reserved under a block listing and will be issued under the Company’s Share Option Plan and the Savings Related Share Option Scheme. This move is likely to enhance Cohort’s financial flexibility and support its growth strategy, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:CHRT) stock is a Buy with a £1570.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc’s subsidiary, Systems Engineering Assessment Ltd (SEA), has secured a significant £8 million contract with Thales UK as part of the 15-year Maritime Sensor Enhancement Team (MSET) programme. This 5-year contract involves providing maintenance and support for the Royal Navy’s towed array handling equipment, enhancing Cohort’s visibility of future revenues and reinforcing its position as a key provider in naval defence systems.
Cohort plc announced that its subsidiary, Systems Engineering Assessment Ltd (SEA), has secured a significant 15-year contract worth £8 million with Thales UK as part of the Maritime Sensor Enhancement Team programme. This contract, which involves providing maintenance and support for the Royal Navy’s towed array handling equipment, reinforces SEA’s reputation as a reliable provider of advanced naval systems and strengthens Cohort’s long-term revenue visibility.
Cohort plc has announced its total voting rights as of April 30, 2025, with an issued share capital of 46,682,990 ordinary shares, each carrying one vote. This update is in accordance with the FCA’s Disclosure Guidance and Transparency Rule, allowing shareholders to calculate their interests in the company’s shares. This announcement reflects Cohort’s commitment to transparency and regulatory compliance, which may impact shareholder engagement and market perception.
Cohort plc announced that Simon Walther, the Finance Director, and Phillippa Walther-Caine, a person closely associated with him, conducted ‘Bed and ISA’ transactions involving the sale and repurchase of shares. These transactions, executed on 23 April 2025, resulted in a slight change in their beneficial interest in Cohort’s shares. This announcement reflects routine financial management activities by key personnel and is unlikely to have significant implications for the company’s operations or market positioning.
Cohort plc announced that Andrew Thomis, the Chief Executive, and Yasmin Thomis, a person closely associated, executed ‘Bed and ISA’ transactions involving the sale and repurchase of shares into Individual Savings Accounts. Additionally, Yasmin Thomis sold shares to contribute to their sons’ ISAs. These transactions reflect strategic financial management by the company’s leadership, potentially impacting stakeholders’ perceptions of executive confidence and investment strategies.
Cohort plc announced its total voting rights as of March 31, 2025, with an issued share capital of 46,649,226 ordinary shares, each carrying one vote. This update is crucial for shareholders to determine their notification requirements under the FCA’s Disclosure Guidance and Transparency Rules, reflecting the company’s commitment to transparency and regulatory compliance.
Cohort plc announced that dividends received by its Chief Executive, Andrew Thomis, and his closely associated persons were automatically reinvested in the company’s shares. This transaction increased their beneficial interest to 264,524 shares, representing 0.57% of the company’s total issued share capital. The reinvestment highlights the executive’s continued confidence in the company’s prospects, potentially impacting stakeholder perception positively.
Cohort plc announced its total voting rights as of February 28, 2025, with an issued share capital of 46,607,938 ordinary shares, each carrying one vote. This update is in line with the FCA’s Disclosure Guidance and Transparency Rule, allowing shareholders to calculate their interests in the company’s shares. The announcement reflects Cohort’s commitment to transparency and regulatory compliance, potentially impacting shareholder decisions and market perceptions.